CenterPoint Energy, Inc. (CNP - Free Report) is set to report fourth-quarter and 2018 results on Feb 28, before the opening bell.
In the last reported quarter, the company witnessed a negative earnings surprise of 4.88%. However, it surpassed the Zacks Consensus Estimate in two of the trailing four quarters, the average beat being 5.97%.
Let’s see how things are shaping up prior to this announcement.
Factors Under Consideration
CenterPoint Energy's major service territories experienced warmer-than-normal winter in the fourth quarter. This, in turn, is likely to impair demand for electricity, resulting in decreased household expenditure for heating.
However, rate relief and customer growth are expected to boost the company’s top line in the quarter to be reported.
The Zacks Consensus Estimate for the company’s fourth-quarter revenues is pegged at $2.66 billion, reflecting a 0.8% increase year over year.
In the third quarter, CenterPoint Energy's earnings benefited from lower federal income tax rate related to the latest U.S. tax reform along with utility rate relief and customer growth. This trend is expected to boost its bottom line in the fourth quarter as well.
Moreover, factors like rate relief, lower federal income tax rate related to tax reform, midstream investments and customer growth are expected to steadily bolster CenterPoint’s earnings in the soon-to-be-reported quarter. The Zacks Consensus Estimate for fourth-quarter earnings stands at 36 cents, reflecting an annual improvement of 9.1%.
Our proven model does not show an earnings beat for CenterPoint Energy this quarter. That is because a stock needs to have both — a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) — for this to happen. That is not the case here, as you will see below.
Earnings ESP: CenterPoint Energy has an Earnings ESP of 0.00%. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Zacks Rank: The company currently carries a Zacks Rank #3, which along with an Earnings ESP of 0.00%, makes surprise prediction difficult.
Note that we caution against stocks with a Zacks Rank #4 or 5 (Sell-rated) going into the earnings announcement, especially when the company is seeing negative estimate revisions.
Edison International (EIX - Free Report) has a Zacks Rank #3. The company is slated to report fourth-quarter 2018 results on Feb 28. You can see the complete list of today’s Zacks #1 Rank stocks here.
PNM Resources, Inc. (PNM - Free Report) carries a Zacks Rank #3. The company is slated to report fourth-quarter 2018 results on Feb 27.
PG&E Corp. (PCG - Free Report) carries a Zacks Rank #3. The company is slated to report fourth-quarter 2018 results on Feb 28.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>